⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31510124 | 0.83 | LMNA (0.39) | — | |
| SCHEMBL1039434 | 0.83 | ALDH1A1 (0.43) | — | |
| SCHEMBL13844086 | 0.81 | CA12 (0.61) | — | |
| SCHEMBL14241060 | 0.79 | ALDH1A1 (0.47) | — | |
| SCHEMBL3337626 | 0.78 | LMNA (0.64) | — | |
| SCHEMBL4992699 | 0.78 | CA12 (0.54) | — | |
| SCHEMBL20200082 | 0.78 | ALDH1A1 (0.38) | — | |
| SCHEMBL2327551 | 0.75 | LMNA (0.78) | — | |
| SCHEMBL6244448 | 0.75 | — | — | |
| SCHEMBL139066 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9770514-B2 | Tamper-resistant pharmaceutical dosage forms | ExxPharma Therapeutics LLC (US) | 2017-09-26 | — | — | US | claimed |
| US-20150064250-A1 | Tamper-Resistant Pharmaceutical Dosage Forms | ExxPharma Therapeutics LLC (US) | 2015-03-05 | — | — | US | claimed |
| US-7214381-B2 | Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels | ANTARES PHARMA IPL AG (CH) | 2007-05-08 | — | — | US | claimed |
| US-20030199426-A1 | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels | ANTARES PHARMA, INC. | 2003-10-23 | — | — | US | claimed |
| EP-1323431-A2 | Composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels | Antares Pharma IPL AG (CH) | 2003-07-02 | — | — | EP | claimed |
| EP-1307232-A1 | NOVEL COMPOSITION FOR TRANSDERMAL AND/OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE COMPOUNDS THAT ENSURES ADEQUATE THERAPEUTIC LEVELS | Antares Pharma IPL AG (CH) | 2003-05-07 | — | — | EP | claimed |
| WO-2002006826-B1 | SINGLE-PATIENT DRUG TRIALS USED WITH ACCUMULATED DATABASE | OPT E SCRIP INC (US) | 2002-04-04 | — | — | WO | claimed |
| US-20020032581-A1 | Single-patient drug trials used with accumulated database: risk of habituation | OPT-E-SCRIP, INC. | 2002-03-14 | — | — | US | claimed |
| WO-2002011768-A1 | NOVEL COMPOSITION FOR TRANSDERMAL AND/OR TRANSMUCOSAL ADMINISTRATION OF ACTIVE COMPOUNDS THAT ENSURES ADEQUATE THERAPEUTIC LEVELS | ANTARES PHARMA IPL AG (CH) | 2002-02-14 | — | — | WO | claimed |
| WO-2002006826-A1 | SINGLE-PATIENT DRUG TRIALS USED WITH ACCUMULATED DATABASE | OPT-E-SCRIP, INC. (US) | 2002-01-24 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| CN-114890994-B | Histamine receptor antagonist and preparation thereof | 成都施贝康生物医药科技有限公司 | 2024-08-02 | — | — | CN | disclosed |
| US-20240254081-A1 | CATALYTIC TRYPTAMINE PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2024-08-01 | — | — | US | disclosed |
| US-4028093-A | Meta-bis anilide derivatives and their utility as herbicides | STAUFFER CHEMICAL COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-4018813-A | HERBICIDES | STAUFFER CHEMICAL COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-3941581-A | Meta-bis anilide derivatives and their utility as herbicides | STAUFFER CHEMICAL COMPANY (US) | 1976-03-02 | — | — | US | disclosed |
| US-3937729-A | META-BIS ANILIDE DERIVATIVES AND THEIR UTILITY AS HERBICIDES | STAUFFER CHEMICAL COMPANY (US) | 1976-02-10 | — | — | US | disclosed |